企業プロフィール
Eli Lilly 株価・ニュース・カタリスト
- ティッカー:
- LLY
- 取引所:
- NYSE
- セクター:
- Biopharma, mRNA Vaccines, Vaccines, Oncology, Small Molecule Drugs
- 所在地:
- United States
株価パフォーマンス
1,183.16 USD (+0.25%)
終値
最終更新: 2026年8月17日
949B USD
時価総額
株価変動の要因
As of Aug 17, 2026, LLY closed up 0.25% at $1183.16. No new same-company headline was identified in the current news window.
企業概要
事業概要
Eli Lilly is a large-cap pharmaceutical company with major exposure to obesity, diabetes, neuroscience, and immunology. The company has become one of the market’s clearest growth stories thanks to its metabolic franchise and broad pipeline.
所在地とセクター分類
Headquartered in the United States and listed on NYSE, Lilly is a global pharma company with a strong commercial presence across major markets. Its investor identity is built around growth, execution, and blockbuster product momentum.
ビジネスモデルの特徴
Lilly combines blockbuster product revenue with a deep late-stage pipeline and major manufacturing investment. Investors watch demand, supply expansion, pipeline progress, and whether the company can keep scaling its metabolic and specialty franchises.
バイオ業界での位置付け
Lilly sits at the top tier of large-cap healthcare because it has both scale and strong growth visibility. Compared with smaller biotech names, the stock is less binary but still highly sensitive to launch execution and pipeline durability.
今後のカタリスト
- Eli Lilly’s next catalysts are still centered on orforglipron, obesity and diabetes filing progress, and retatrutide development and manufacturing readiness. The next checkpoint matters because it tells investors whether the program is still moving on schedule or whether the timeline needs to be reset. A clean outcome also makes it easier to think about the next regulatory or label step instead of just the current filing.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。